Deontics Secures a Six‑Figure Boost From the Coronavirus Future Fund
Shakespeare Martineau has just pulled the trigger on a cool £600,000 loan for London‑based Deontics, the company crafting AI tools that help doctors make life‑saving decisions. The funding comes from a government‑backed scheme that pairs funding of £125,000 to £5 million for businesses tackling the pandemic.
Why Deontics Matters
- Deontics’ software isn’t just any spreadsheet – it’s a sophisticated AI system that’s already been trusted by cardiac specialists at the Royal Liverpool Hospital.
- In April 2020, they rolled out the first executed COVID‑19 treatment pathway, turning raw data into real‑world guidance.
- These tools help doctors decide on treatments faster and with more confidence, a game‑changer when time is a precious resource.
The Deal Behind the Scenes
Acting as the company’s financial gatekeepers, Adam McGiveron and Emma Bryant guided Deontics through the application process, ensuring the corporate structure was all set to snag the convertible loan. Adam summed it up: “The Future Fund is a brilliant opportunity for businesses like ours to finance growth and reinforce stability.”
Quotes from the Crew
Adam McGiveron: “We’re excited to help Deontics secure this investment – it’s going to let them bring their world‑leading tech to customers worldwide.”
James Whitticase, Chair of Deontics: “This funding marks a pivotal chapter for us, giving us the solid footing we need for the next wave of expansion.”
What’s Next for Deontics?
With fresh capital in hand, Deontics plans to enhance its AI platform, explore untapped markets, and continue delivering cutting‑edge solutions to the global medical community.
Stay in the loop: Subscribe now for real‑time updates on Deontics’ journey straight to your device.
